drugset / Trial / NCT04666701

Efficacy and Safety of Escócia Association in the Treatment of Acute Pain

NCT04666701 ↗

Phase 2 Withdrawn EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Escócia association in adults with acute pain.

Timeline

Start
2023-02
Primary completion
2025-02
Completion
2025-06

Outcome

Outcome not reported

Stopped (Business): “Strategy review”

Drugs

EvaluationDrugModalityDoseRoute
Subject Escócia association Unknown — Oral
Comparator Ketorolac Tromethamine Small molecule — Subcutaneous
Comparator Scopolamine Unknown — Oral

Indications

No indication recorded.